Aberrant HLA-G expression in cancers was first reported in 1998 (11), and studies later documented that up-regulated HLA-G expression could only be found in primary and metastatic melanoma cells; but not in tumor regression sites or in normal adjacent skin tissues from a melanoma patient (83, 84). Here, HLA-G is linked to neoplasm.